Hans has made over 7 trades of the Agilent Technologies stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 270,250 units of A stock worth $12,477,443 on 16 January 2018.
The largest trade he's ever made was selling 270,250 units of Agilent Technologies stock on 16 January 2018 worth over $12,477,443. On average, Hans trades about 23,029 units every 23 days since 2016. As of 16 January 2018 he still owns at least 2,502,429 units of Agilent Technologies stock.
You can see the complete history of Mr. Bishop stock trades at the bottom of the page.
Hans Edgar Bishop serves as Independent Director of the Company. Mr. Bishop has served as Chief Executive Officer of GRAIL, Inc. since June 2019, and served as a member of GRAIL’s Board of Directors since August 2016. He has served as a member of the Board of Directors of Celgene, Inc. since April 2018. Mr. Bishop served as President, Chief Executive Officer and a member of the Board of Directors of Juno Therapeutics, Inc. from September 2013 to March 2018 when Juno was acquired by Celgene Corporation. From February 2012 until October 2012, Mr. Bishop was the chief operating officer of Photothera Inc., a late-stage medical device company owned by Warburg Pincus, and he continued working with Warburg Pincus as an Executive in Residence until October 2013. Prior to joining Photothera Inc., Mr. Bishop served as executive vice president and chief operating officer at Dendreon Corporation, a publicly-traded biopharmaceutical company, from January 2010 to September 2011. Mr. Bishop has also served as the president of the specialty medicine business at Bayer Healthcare Pharmaceuticals Inc. from December 2006 to January 2010, where he was responsible for a diverse portfolio of neurology, oncology and hematology products. Mr. Bishop brings a valuable set of skills to the Board through his broad experience as an operating officer within the pharmaceutical industry and executive experience in the biotechnology industry.
As the Independent Director of Agilent Technologies, the total compensation of Hans Bishop at Agilent Technologies is $331,486. There are 15 executives at Agilent Technologies getting paid more, with Michael McMullen having the highest compensation of $12,520,600.
Over the last 22 years, insiders at Agilent Technologies have traded over $170,735,833 worth of Agilent Technologies stock and bought 25,786 units worth $823,096 . The most active insiders traders include William P Sullivan, George A Scangos, and Mikael Dolsten. On average, Agilent Technologies executives and independent directors trade stock every 20 days with the average trade being worth of $3,748,368. The most recent stock trade was executed by Padraig Mcdonnell on 22 August 2024, trading 1,958 units of A stock currently worth $283,910.
analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.
Agilent Technologies executives and other stock owners filed with the SEC include: